ACE2 and COVID-19: Since adipose tissue abundantly expresses ACE2 [62,63], it was hypothesized that it might serve as a viral reservoir enabling viral shedding, immune activation, and cytokine amplification, predisposing obese COVID-19 patients to a severe course of the disease [60].